FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Website:

https://www.fda.gov/news-events/press-announcements/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs

Subreddit: UpliftingNews

Author: -Mystica-

Comments: 1

Score: 7

Google News RSS

https://news.google.com/rss/search?q=fda-announces-plan-to-phase-out-animal-testing-requirement-for-monoclonal-antibodies-and-other-drugs

Latest Articles Fetched Here

FDA plans to end animal testing requirements for monoclonal antibody drugs Fierce Biotech
FDA approves new canine otitis externa medication DVM360
FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs CNN
FDA plans to phase out animal testing in drugs in what it calls a ‘paradigm shift’ statnews.com
US FDA to phase out animal testing in drug development Reuters
FDA plans to phase out animal testing for some drugs BioPharma Dive
FDA plans to phase out animal testing requirements Axios
Humane World for Animals and Humane World Action Fund Applaud FDA’s Historic Move to Phase Out Animal Testing for Biologics and Drugs Sierra Sun Times
FDA To Phase Out Animal Testing Requirements Technology Networks
Insight on FDA’s Plan to Phase Out Animal Testing for mAbs and Other Drugs Contract Pharma
CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies PR Newswire
FDA Removing Animals from Antibody Tests is a Game Changer PETA
FDA phasing out some animal testing in 'win-win' for ethics and public health: commissioner Fox News
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements Benzinga
Industry Outlook 2025: Looking at the Mega Trends PharmTech
FDA to phase out animal testing with AI and lab-based models Pharmaceutical Technology
Kudos to the FDA and EPA for planning to phase out animal testing Utah News Dispatch
The Intersection of Chemistry, Robotics, and AI in Drug Discovery (BIO 2024) PharmTech
FDA's Center for Veterinary Medicine names new director DVM360
Therapy for canine idiopathic epilepsy receives FDA conditional approval DVM360
4 recent FDA updates DVM360
DCAT Week 2025: Keeping Up with Drug Demand BioPharm International
Takeda’s Subcutaneous Immunoglobulin Receives FDA Approval for Maintenance Therapy of Rare Neuromuscular Disorder BioPharm International
DCAT Week 2025: Recognizing the Value of CDMOs BioPharm International
Lonza Launches New Cell Line for Higher Potency Antibody Development PharmTech
Tariff Pause Reinforces Uncertainty Among Biopharma Professionals BioPharm International
Distinguishing E&L Testing for Combination Products (AAPS PharmSci 360) BioPharm International
SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation BioPharm International
FDA Approves First Gene Therapy for Pediatric MLD from Orchard Therapeutics, and AGC Biologics Tapped to Manufacture It BioPharm International
INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption PharmTech
Ardena Expands Bioanalytical Services in the Netherlands PharmTech
Camena Bioscience Raises $10 Million to Pursue DNA Synthesis Technology BioPharm International
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma PharmTech
Illuminating the State of Outsourcing with Stephen Houldsworth (DCAT 2023) PharmTech
Considerations for Sterile Filtration of Biologic Drugs PharmTech
Overcoming Challenges in the Reconstitution of a High-Concentration Protein Drug Product BioPharm International
Top 1000 Global Biomanufacturing Facilities BioPharm International
A Rational Approach for Setting and Maintaining Specifications for Biological and Biotechnology–Derived Products—Part 3 BioPharm International
PQRI Case Study (2): Functional Equivalence for Equipment Replacements PharmTech
The combination drugs debate: Incompatibility problems can be overcome PharmTech